These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9084749)

  • 41. Regression of brain metastases from breast carcinoma after chemotherapy with bendamustine.
    Zulkowski K; Kath R; Semrau R; Merkle K; Höffken K
    J Cancer Res Clin Oncol; 2002 Feb; 128(2):111-3. PubMed ID: 11862482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [International statistics on gynecological cancer are compiled in Stockholm].
    Pettersson F
    Lakartidningen; 1992 Dec; 89(50):4410-2. PubMed ID: 1469984
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term survival in a patient with brain metastases preceding the diagnosis of endometrial cancer. Report of two cases and review of the literature.
    Petru E; Lax S; Kurschel S; Gücer F; Sutter B
    J Neurosurg; 2001 May; 94(5):846-8. PubMed ID: 11354422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Psammoma bodies found in cervicovaginal and/or endometrial smears.
    Fujimoto I; Masubuchi S; Miwa H; Fukuda K; Yamaguchi S; Masubuchi K
    Acta Cytol; 1982; 26(3):317-22. PubMed ID: 6954813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Genital metastases in cancer of the ovary].
    Ganchev S
    Akush Ginekol (Sofiia); 1980; 19(4):335-41. PubMed ID: 7416413
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment and prognosis of brain metastases from gynecological cancers.
    Ogawa K; Yoshii Y; Aoki Y; Nagai Y; Tsuchida Y; Toita T; Kakinohana Y; Tamaki W; Iraha S; Adachi G; Hirakawa M; Kamiyama K; Inamine M; Hyodo A; Murayama S
    Neurol Med Chir (Tokyo); 2008 Feb; 48(2):57-62; discussion 62-3. PubMed ID: 18296873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is endometrial cancer really a neurophobic tumor? A case report and review of the literature.
    Nassir M; Roth A; Gasimli K; Braicu EI; Fotopoulou C; Mawrin C; Badakhshi H; Warnke JP; Sehouli J
    Anticancer Res; 2014 Jan; 34(1):249-57. PubMed ID: 24403471
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What is the optimal venous thromboembolism prophylaxis for gynecological oncology patients with CNS metastases?
    Baggott CD; Einstein MH; Miranpuri A; Rose SL; Kuo JS
    Gynecol Oncol; 2011 Nov; 123(2):409-10. PubMed ID: 21807402
    [No Abstract]   [Full Text] [Related]  

  • 49. Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands.
    Burg L; Timmermans M; van der Aa M; Boll D; Rovers K; de Hingh I; van Altena A
    J Gynecol Oncol; 2020 Sep; 31(5):e58. PubMed ID: 32808491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary brain metastases of endometrial cancer: A report of 18 cases and review of the literature.
    Uccella S; Morris JM; Multinu F; Cliby WA; Podratz KC; Gostout BS; Dowdy SC; Ghezzi F; Makdisi PB; Keeney GL; Link MJ; Mariani A
    Gynecol Oncol; 2016 Jul; 142(1):70-75. PubMed ID: 27095189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is thrombocytosis a valid indicator of advanced stage and high mortality of gynecological cancer?
    Andersen CL; Eskelund CW; Siersma VD; Felding P; Lind B; Palmblad J; Bjerrum OW; Friis S; Hasselbalch HC; de Fine Olivarius N
    Gynecol Oncol; 2015 Nov; 139(2):312-8. PubMed ID: 26407478
    [No Abstract]   [Full Text] [Related]  

  • 52. Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review.
    Tangjitgamol S; Levenback CF; Beller U; Kavanagh JJ
    Int J Gynecol Cancer; 2004; 14(3):399-422. PubMed ID: 15228413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proteomic analysis of differential protein expression by brain metastases of gynecological malignancies.
    Yoshida A; Okamoto N; Tozawa-Ono A; Koizumi H; Kiguchi K; Ishizuka B; Kumai T; Suzuki N
    Hum Cell; 2013 Jun; 26(2):56-66. PubMed ID: 23504277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic factors for patients with brain metastasis from gynecological cancer: a significance of treatment-free interval of more than 6 months.
    Takeshita S; Todo Y; Furuta Y; Okamoto K; Minobe S; Yamashiro K; Kato H
    Jpn J Clin Oncol; 2017 Jul; 47(7):604-610. PubMed ID: 28398498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain Metastases from Gynecologic Malignancies.
    Karpathiou G; Camy F; Chauleur C; Dridi M; Dal Col P; Peoc'h M
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454386
    [No Abstract]   [Full Text] [Related]  

  • 56. Endometrial cancer metastasis to brain: report of two cases and a review of the literature.
    Wroński M; Zakowski M; Arbit E; Hoskins WJ; Galicich JH
    Surg Neurol; 1993 May; 39(5):355-9. PubMed ID: 8493593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical trials in gynecological cancer.
    Trimble EL; Davis J; Disaia P; Fujiwara K; Gaffney D; Kristensen G; Ledermann J; Pfisterer J; Quinn M; Reed N; Schoenfeldt M; Thigpen JT;
    Int J Gynecol Cancer; 2007; 17(3):547-56. PubMed ID: 17504371
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain metastases from epithelial ovarian cancer--report of cases.
    Stanisławiak J; Lubin J; Markowska J
    Eur J Gynaecol Oncol; 2009; 30(6):683-5. PubMed ID: 20099505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathology of cerebral metastases.
    Takahashi JA; Llena JF; Hirano A
    Neurosurg Clin N Am; 1996 Jul; 7(3):345-67. PubMed ID: 8823768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Histological observations on hilar cells in some obstetrical and gynecological pathological conditions].
    Ragucci N; Allocca G
    Arch Ostet Ginecol; 1972; 77(6):445-63. PubMed ID: 4681770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.